Cencora

COR Health Care Market cap $62.3B as of Sep 14, 2026 16:00 ET S&P 500

Q3 FY26 Apr 1 – Jun 30, 2026 reported Aug 5, 2026

Revenue$84.76B +5% year over year

Gross profit$3.61B 4% margin

Operating profit$1.12B 1% margin

Net profit$0.76B 1% margin

The numbers behind the diagram

All figures in billions of U.S. dollars, for Q3 FY26 (period ends Jun 30, 2026).
Item	Value	Share of revenue	Year over year
Segment revenue	84.80	100%
U.S. healthcare	74.86	88%
Alliance healthcare	6.60	8%
Animal health	1.52	2%
Other healthcare	1.08	1%
Non-strategic businesses	0.73	1%
Eliminations	−0.04	−0%
Net revenue	84.76	100%	+5%
Cost of revenue	−81.15	96%
Gross profit	3.61	4% margin	+1pp
SG&A	−2.13	3%	+0pp
Other	−0.36	0%	+0pp
Operating profit	1.12	1% margin	+0pp
Interest & other costs	−0.14
Tax	−0.22
Net profit	0.76	1% margin	+0pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q4 FY25 (period ends Sep 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	83.73	100%	+6%
US healthcare solutions	75.79	91%	+6%
International healthcare	7.95	9%	+8%
Cost of revenue	−80.78	96%
Gross profit	2.95	4% margin
SG&A	−1.75	2%	+0pp
Other	−1.19	2%	+0pp
Operating profit	0.02	0% margin	+0pp
Interest & other costs	−0.21
Tax	−0.15
Net profit	−0.34	0% margin	+0pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Jun 30, 2025).
Item	Value	Share of revenue	Year over year
Revenue	80.66	100%	+9%
US healthcare solutions	72.88	90%	+8%
International healthcare	7.79	10%	+10%
Cost of revenue	−77.76	96%
Gross profit	2.91	4% margin
SG&A	−1.67	2%	+0pp
Other	−0.37	1%	+0pp
Operating profit	0.87	1% margin	+0pp
Tax	−0.18
Net profit	0.69	1% margin	+0pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q4 FY24 (period ends Sep 30, 2024).
Item	Value	Share of revenue	Year over year
Revenue	79.05	100%	+15%
US healthcare solutions	71.67	91%	+16%
International healthcare	7.38	9%	+6%
Cost of revenue	−76.56	97%
Gross profit	2.49	3% margin	+0pp
SG&A	−1.49	2%	+0pp
Other	−0.88	1%	+0pp
Operating profit	0.13	0% margin	−1pp
Tax	−0.12
Net profit	<0.01	0% margin	−1pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY24 (period ends Jun 30, 2024).
Item	Value	Share of revenue	Year over year
Revenue	74.24	100%	+11%
US healthcare solutions	67.19	91%	+12%
International healthcare	7.05	9%	+0%
Cost of revenue	−71.83	97%
Gross profit	2.41	3% margin	+0pp
SG&A	−1.38	2%	+0pp
Other	−0.36	0%	+0pp
Operating profit	0.67	1% margin	+0pp
Tax	−0.19
Net profit	0.48	1% margin	+0pp

Filing on EDGAR This quarter on its own page

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

Every set of results we hold, newest first. Open one on its own page.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q3 FY26 Apr 1 – Jun 30, 2026 reported Aug 5, 2026 Operating margin 1% Net profit $0.76B	Apr 1 – Jun 30, 2026	Aug 5, 2026	$84.8B	+5%	1%	$0.76B	1%
Q4 FY25 Jul 1 – Sep 30, 2025 reported Nov 25, 2025 Operating margin 0% Net profit −$0.34B	Jul 1 – Sep 30, 2025	Nov 25, 2025	$83.7B	+6%	0%	−$0.34B	0%
Q3 FY25 Apr 1 – Jun 30, 2025 reported Aug 6, 2025 Operating margin 1% Net profit $0.69B	Apr 1 – Jun 30, 2025	Aug 6, 2025	$80.7B	+9%	1%	$0.69B	1%
Q4 FY24 Jul 1 – Sep 30, 2024 reported Nov 26, 2024 Operating margin 0% Net profit $<0.01B	Jul 1 – Sep 30, 2024	Nov 26, 2024	$79.1B	+15%	0%	$<0.01B	0%
Q3 FY24 Apr 1 – Jun 30, 2024 reported Jul 31, 2024 Operating margin 1% Net profit $0.48B	Apr 1 – Jun 30, 2024	Jul 31, 2024	$74.2B	+11%	1%	$0.48B	1%